These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10122038)

  • 1. Inhalation devices--which is best for your patient?
    Yule H
    Hosp Pharm; 1992 Nov; 27(11):1010-2, 1015. PubMed ID: 10122038
    [No Abstract]   [Full Text] [Related]  

  • 2. Aerosol generators and delivery systems.
    Newman SP
    Respir Care; 1991 Sep; 36(9):939-51. PubMed ID: 10145539
    [No Abstract]   [Full Text] [Related]  

  • 3. AARC clinical practice guideline. Selection of aerosol delivery device. American Association for Respiratory Care.
    Respir Care; 1992 Aug; 37(8):891-7. PubMed ID: 10145780
    [No Abstract]   [Full Text] [Related]  

  • 4. Paediatric pulmonary drug delivery: considerations in asthma treatment.
    Berger WE
    Expert Opin Drug Deliv; 2005 Nov; 2(6):965-80. PubMed ID: 16296802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of MDI (metered dose inhaler) spacers and adapters: their effect on the respirable volume of medication.
    Ebert J; Adams AB; Green-Eide B
    Respir Care; 1992 Aug; 37(8):862-8. PubMed ID: 10145777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for devices and choices.
    Everard ML
    J Aerosol Med; 2001; 14 Suppl 1():S59-64. PubMed ID: 11424895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AARC (American Association of Respiratory Care) clinical practice guideline. Selection of an aerosal delivery device for neonatal and pediatric patients.
    Respir Care; 1995 Dec; 40(12):1325-35. PubMed ID: 10153259
    [No Abstract]   [Full Text] [Related]  

  • 8. Could interchangeable use of dry powder inhalers affect patients?
    Price D; Summers M; Zanen P
    Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
    Westerman EM; Heijerman HG; Frijlink HW
    Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.
    Knoch M; Keller M
    Expert Opin Drug Deliv; 2005 Mar; 2(2):377-90. PubMed ID: 16296761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Montreal Protocol and metered dose inhalers.
    Navarro RP
    Med Interface; 1997 Apr; 10(4):135-6. PubMed ID: 10166800
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhalation therapy: techniques and use of devices--main mistakes].
    Voshaar T
    Med Klin (Munich); 2002 Dec; 97 Suppl 2():2-6. PubMed ID: 12593174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and intelligent inhaler device development.
    Tobyn M; Staniforth JN; Morton D; Harmer Q; Newton ME
    Int J Pharm; 2004 Jun; 277(1-2):31-7. PubMed ID: 15158967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly reproducible powder aerosolisation for lung delivery using powder-specific electromechanical vibration.
    Crowder TM
    Expert Opin Drug Deliv; 2005 May; 2(3):579-85. PubMed ID: 16296776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilating efficacy of an open-spacer device compared to three other spacers.
    Tschopp JM; Robinson S; Caloz JM; Frey JG
    Respir Care; 1992 Jan; 37(1):61-4. PubMed ID: 10145582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CFC transition.
    Morice AH
    Thorax; 2001 Jun; 56(6):501-2. PubMed ID: 11403035
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery systems: an in vitro study.
    Van Dyke RE; Nikander K
    Respir Care; 2007 Feb; 52(2):184-90. PubMed ID: 17261207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of realistic airflow rate on aerosol generation by nebulizers.
    Vecellio L; Kippax P; Rouquette S; Diot P
    Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Practice guidelines of aerosol therapy through nebulization. Proposals from the National Assizes on Nebulization, Paris, April 4-5, 1997 (version from September 15 1997)].
    Arch Pediatr; 1998 Feb; 5(2):175-80. PubMed ID: 10223140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.